Japan Passes Legislation to Legalize Marijuana Derivative Drugs

Regulations by 2FIRSTS.ai
Dec.07.2023
Japan Passes Legislation to Legalize Marijuana Derivative Drugs
The Japanese Parliament has passed a legislation amendment to legalize marijuana-derived drugs for medical use.

According to a report by Agence France-Presse on December 6th, the Japanese Parliament (known as the "Diet") has passed a legislative amendment aimed at legalizing medicinal derivatives of marijuana. The amendment seeks to address the existing legal loophole regarding the punishment for recreational use of the drug.

 

Previously, Japan only permitted drugs derived from cannabis for use in clinical trials. However, patients have consistently been requesting access to these drugs, specifically cannabidiol products derived from this plant. These products have already been approved in Europe and the United States for the treatment of conditions such as refractory epilepsy.

 

According to the amendment, the use of marijuana-derived medicines will be permitted, along with the cultivation of this plant for sourcing raw materials for pharmaceutical and other products. The amendment was passed by the Japanese House of Representatives this Wednesday, with majority support from the ruling coalition.

 

The revision of the Cannabis Control Law will come into effect one year after its promulgation, and it will entail the formulation of new regulations regarding cannabis and tetrahydrocannabinol (THC), a psychoactive substance found in the cannabis plant.

 

In a groundbreaking move for the country, these substances will be categorized as narcotics, according to the national Controlled Substances and Psychotropic Substances Act, effectively prohibiting and penalizing possession, transfer, or consumption of these substances.

 

Despite the cultivation, possession, and sale of marijuana being prohibited and punished in Japan, the use of these specific substances is currently not penalized. However, this situation is expected to change once the revised law comes into effect, with recreational usage potentially resulting in up to seven years of imprisonment.

 

The reason why there are no punishments for marijuana use in Japan under this law is due to its widespread traditional uses such as clothing production, seasoning, or significant religious ceremonies associated with Shintoism, a native religion in Japan.

 

However, due to the increasing number of arrests related to cannabis, especially among young people in their twenties, the Japanese authorities have decided to regulate this issue. These new measures will introduce two different types of cannabis cultivation licenses – one for medical purposes and another for other purposes such as manufacturing cannabis-based products, including clothing.

 

These legal changes regarding the cultivation of marijuana will come into effect two years after being issued.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | HAYATI Launches Nicotine Pouches with Cooling Flavors, Targeting UK and UAE Markets
Product | HAYATI Launches Nicotine Pouches with Cooling Flavors, Targeting UK and UAE Markets
HAYATI has launched HAYATI NIC POUCHES, offering nicotine strengths from 6mg to 30mg and a range of cooling “ice” flavors, now available in the UK and UAE markets. Its open-system sub-brand QUOKKA has also debuted on the official website, with the parent company filing related trademarks.
Jul.17 by 2FIRSTS.ai
Kenya Announces a Complete Ban on All Tobacco Product Imports, Health Minister: Public Health Takes Priority
Kenya Announces a Complete Ban on All Tobacco Product Imports, Health Minister: Public Health Takes Priority
Kenya has banned the import of all tobacco products to reduce supply and tackle health issues. The Health Minister emphasized continuing efforts against illegal tobacco smuggling and announced stricter graphic health warnings to protect youth from tobacco harms.
Aug.04 by 2FIRSTS.ai
U.S. FDA to Review Philip Morris International’s IQOS Risk Modification Renewal Application in October
U.S. FDA to Review Philip Morris International’s IQOS Risk Modification Renewal Application in October
The U.S. FDA will review Philip Morris International’s renewal application for five IQOS products' modified risk status at an October 7 TPSAC meeting, evaluating whether they still meet the required standards.
Jul.30 by 2FIRSTS.ai
U.S. Court Formally Approves Imperial Tobacco Canada Restructuring Plan Involving US$23.6 Billion Settlement
U.S. Court Formally Approves Imperial Tobacco Canada Restructuring Plan Involving US$23.6 Billion Settlement
The U.S. Bankruptcy Court in New York has approved and recognized the restructuring plan of Imperial Tobacco Canada Ltd., granting legal effect in the U.S. to its participation in a CA$32.5 billion (US$23.6 billion) tobacco litigation settlement. The case is considered one of the largest corporate restructurings in Canadian history and also involves Japan Tobacco International (JTI), Philip Morris International (PMI), and British American Tobacco (BAT).
Aug.28 by 2FIRSTS.ai
Product | OXBAR DUALBLEND Launches in the Middle East, Claims 35 Flavor Experiences in One Device
Product | OXBAR DUALBLEND Launches in the Middle East, Claims 35 Flavor Experiences in One Device
E-cigarette brand OXBAR has recently launched its new OXBAR DUAL BLEND 35K on a Middle Eastern distributor website. Featuring dual e-liquid tanks, the product claims to offer up to 35 flavor experiences and includes a smart LED screen displaying battery and e-liquid levels. Previously unveiled at the Dubai Vape Expo, it is priced at approximately $20–$26.
Aug.01 by 2FIRSTS.ai
Thailand's E-Cigarette Crackdown: 4 Million Items Seized, 11,000 URLs Blocked
Thailand's E-Cigarette Crackdown: 4 Million Items Seized, 11,000 URLs Blocked
Thai government crackdown on illegal e-cigarettes results in 3200 arrests, seizure of 4 million products worth $17.89 million.
Aug.25 by 2FIRSTS.ai